These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1347185)
21. Effect of nifedipine on renal allograft function and survival beyond one year. Shin GT; Cheigh JS; Riggio RR; Suthanthiran M; Stubenbord WT; Serur D; Wang JC; Rubin AL; Stenzel KH Clin Nephrol; 1997 Jan; 47(1):33-6. PubMed ID: 9021239 [TBL] [Abstract][Full Text] [Related]
22. Aggressive early cyclosporine therapy is desirable in pediatric renal transplantation. al-Uzri A; Conley SB; Orlandi P; So S; Salvatierra O Transplant Proc; 1994 Feb; 26(1):88-90. PubMed ID: 8109036 [No Abstract] [Full Text] [Related]
23. A 1-year prospective randomized study in Korean living donor kidney transplant recipients: comparing cyclosporine monotherapy and cyclosporine/prednisolone during the maintenance phase of immunosuppression. Park K; Kim ST; Lee SR; Koh YB; Kim HC Transplant Proc; 1994 Aug; 26(4):1985-6. PubMed ID: 8066642 [No Abstract] [Full Text] [Related]
24. Kidney graft function in long-term cyclosporine and tacrolimus treatment: comparative study with nephrotoxicity markers. Marchewka Z; Kuźniar J; Zynek-Litwin M; Falkiewicz K; Szymańska B; Roszkowska A; Klinger M Transplant Proc; 2009 Jun; 41(5):1660-5. PubMed ID: 19545703 [TBL] [Abstract][Full Text] [Related]
25. Studies of cyclosporine-associated arteriolopathy in renal transplantation: does the long-term outcome of renal allografts depend on chronic cyclosporine nephrotoxicity? Takeda A; Morozumi K; Yoshida A; Uchida K; Tominaga Y; Fujinami T; Yokoyama I; Takagi H Transplant Proc; 1994 Apr; 26(2):925-8. PubMed ID: 8171705 [No Abstract] [Full Text] [Related]
26. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy. El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298 [TBL] [Abstract][Full Text] [Related]
27. Calcium antagonists in heart transplant recipients: effects on cardiac and renal function and cyclosporine pharmacokinetics. Legault L; Ogilvie RI; Cardella CJ; Leenen FH Can J Cardiol; 1993 Jun; 9(5):398-404. PubMed ID: 8348391 [TBL] [Abstract][Full Text] [Related]
29. Cyclosporine monotherapy versus conventional therapy in the living-related renal transplant: a one center retrospective study. Masri MA; Shakuntala V; Dhawan IK; Zahir M; Shanwaz M; Hayes K; Pingle A Transplant Proc; 1993 Jun; 25(3):2248-9. PubMed ID: 8516889 [No Abstract] [Full Text] [Related]
30. Effects of nicardipine on blood cyclosporine levels in renal transplant patients. Guan D; Wang R; Lu J; Wang M; Xu C Transplant Proc; 1996 Jun; 28(3):1311-2. PubMed ID: 8658673 [No Abstract] [Full Text] [Related]
31. Analysis of the risk factors of late failure in renal transplantation under cyclosporine immunosuppression. Pallardó LM; Sánchez P; Sánchez J; García J; Beneyto I; Orero E; Rochera A Transplant Proc; 1994 Oct; 26(5):2536-7. PubMed ID: 7940781 [No Abstract] [Full Text] [Related]
32. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients. Gracida C; Melchor JL; Miranda ME; Bartolano C Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191 [No Abstract] [Full Text] [Related]
34. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group. Buchholz B; Korn A Transplant Proc; 1996 Aug; 28(4):2187-8. PubMed ID: 8769195 [No Abstract] [Full Text] [Related]
35. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system. Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721 [TBL] [Abstract][Full Text] [Related]
36. Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial. Halimi JM; Giraudeau B; Buchler M; Al-Najjar A; Etienne I; Laouad I; Bruyère F; Lebranchu Y Clin Transplant; 2007; 21(2):277-84. PubMed ID: 17425758 [TBL] [Abstract][Full Text] [Related]
37. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation. Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104 [No Abstract] [Full Text] [Related]
38. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants. Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888 [No Abstract] [Full Text] [Related]
39. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up. Yoshimura N; Ohmori Y; Tsuji T; Oka T Transplant Proc; 1994 Oct; 26(5):2632-3. PubMed ID: 7940820 [No Abstract] [Full Text] [Related]